Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 29,276 shares at $317.34 ($9.2M) on 2013-10-02, disclosed to the SEC on 2013-10-03.
Scheduled sale ($9.2M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $313.58 | 637 | $200K | 2.2% |
| 2 | $313.58 | 9,152 | $2.9M | 31.3% |
| 3 | $313.58 | 9,726 | $3.0M | 33.2% |
| 4 | $313.58 | 599 | $188K | 2.0% |
| 5 | $312.44 | 1,374 | $429K | 4.7% |
| 6 | $313.44 | 4,594 |
| $1.4M |
| 15.7% |
| 7 | $314.31 | 2,200 | $691K | 7.5% |
| 8 | $315.39 | 400 | $126K | 1.4% |
| 9 | $316.13 | 100 | $32K | 0.3% |
| 10 | $317.34 | 494 | $157K | 1.7% |
| Total | $313.66 avg | 29,276 | $9.2M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |